Mindful Eating in Breast Cancer Survivors: A Pilot Study in Türkiye
MIND-BR
Exploring the Impact of Mindful Eating: A Pilot Study Among Breast Cancer Survivors in Türkiye
1 other identifier
interventional
25
1 country
1
Brief Summary
The goal of this clinical trial is to explore whether a mindful eating intervention can improve eating behaviors and support sustainable weight management among female breast cancer survivors in Türkiye who have completed active treatment. The main questions it aims to answer are:
- Can a structured mindful eating program improve intuitive and mindful eating behaviors?
- Does the intervention lead to favorable changes in body weight, BMI, waist circumference, and fat mass compared to usual care? Researchers will compare a group receiving a 6-session mindful eating intervention plus treatment-as-usual (MEI + TAU) to a treatment-as-usual (TAU) control group to see if the intervention provides additional benefits on eating behaviors and body composition. Participants will:
- Attend six 60-90 minute group sessions on mindful eating delivered by trained professionals
- Receive tailored nutrition education from an oncology dietitian
- Complete validated questionnaires (IES-2 and MEQ-30) and anthropometric assessments at baseline and follow-up
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 3, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 25, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 2, 2024
CompletedFirst Submitted
Initial submission to the registry
May 28, 2025
CompletedFirst Posted
Study publicly available on registry
June 5, 2025
CompletedJune 18, 2025
May 1, 2025
1.8 years
May 28, 2025
June 15, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in Intuitive Eating Score (IES-2 Total)
The Intuitive Eating Scale-2 (IES-2) is a validated tool measuring reliance on internal cues and rejection of dieting. Higher scores reflect greater intuitive eating behavior.
Baseline and 6 months post-intervention
Change in Mindful Eating Score (MEQ-30 Total)
The MEQ-30 evaluates domains such as awareness, emotional eating, disinhibition, and responsiveness to hunger cues. Higher scores indicate stronger mindful eating behaviors.
Baseline and 6 months post-intervention
Secondary Outcomes (3)
Change in Body Fat Mass (kg)
Baseline and 6 months
Change in Fat-Free Mass (kg)
Baseline and 6 months
Change in Waist Circumference (cm)
Baseline and 6 months
Study Arms (2)
Mindful Eating Intervention + Treatment as Usual (MEI + TAU)
EXPERIMENTALParticipants in this group received six structured sessions of a mindful eating intervention over a defined period, each lasting 60-90 minutes. The intervention was delivered by a registered dietitian certified in both Mindful Eating Certificate (The Center of Mindful Eating, EatRight Certified, 2023) and Mindfulness-Based Eating Awareness Training (MB-EAT) (Mindful Eating Training Institute, 2019). These sessions aimed to improve awareness of hunger and satiety cues, reduce emotional eating, and promote healthier eating behaviors. In addition to the behavioral sessions, participants also received standard post-treatment care, including individualized nutritional counseling by an oncology dietitian.
Treatment as Usual (TAU)
ACTIVE COMPARATORParticipants in this group received standard survivorship care, which included individualized nutritional education and counseling delivered by an oncology dietitian. They did not participate in any mindful eating-specific behavioral intervention. This group served as the comparator to evaluate the added effect of the structured mindful eating program.
Interventions
The mindful eating intervention consisted of six structured group sessions delivered over a six-week period, each lasting approximately 60-90 minutes. The sessions were led by a registered dietitian certified in both Mindful Eating (The Center of Mindful Eating, EatRight Certified, 2023) and Mindfulness-Based Eating Awareness Training (MB-EAT, 2019). The curriculum was designed to improve participants' awareness of hunger and satiety cues, reduce emotional eating, enhance eating satisfaction, and foster non-judgmental eating practices. Each session incorporated guided mindfulness practices, cognitive-behavioral techniques, and experiential activities such as sensory-focused eating. The intervention was provided in addition to standard post-treatment care, which included nutritional counseling by an oncology dietitian.
Participants in this group received individualized nutrition counseling and education from a registered oncology dietitian as part of standard post-treatment care for breast cancer survivors. The counseling focused on balanced eating, long-term weight management, and general lifestyle guidance based on survivorship needs. No additional behavioral or mindful eating interventions were delivered.
Eligibility Criteria
You may qualify if:
- Female individuals aged 18 years and older
- History of breast cancer diagnosis (any subtype)
- Completion of active cancer treatment (surgery, chemotherapy, and/or radiotherapy) at least 6 months prior to enrollment
- Ability to participate in group-based behavioral sessions
- Ability to provide informed consent
You may not qualify if:
- Completion of cancer treatment less than 6 months prior to enrollment
- Presence of metastatic disease or active cancer recurrence
- Concurrent diagnosis of another major illness affecting dietary behavior (e.g., eating disorder, severe gastrointestinal disease)
- Cognitive impairment or psychiatric condition that limits ability to participate in behavioral sessions
- Inability or unwillingness to attend group intervention sessions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Acibadem Universitylead
- Acibadem Altunizade Hospital, Istanbulcollaborator
Study Sites (1)
Acıbadem Altunizade Hospital
Istanbul, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 28, 2025
First Posted
June 5, 2025
Study Start
May 3, 2022
Primary Completion
February 25, 2024
Study Completion
May 2, 2024
Last Updated
June 18, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared due to privacy concerns and ethical restrictions. The current study was approved under conditions that limit data use to the research team, and participant-level data were not collected with explicit consent for external sharing. Group-level findings will be reported in scientific publications.